Reblozyl 75 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJF81
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,565
Award facts
- Contract value 100% obligated
- $31,564.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,564.64 to AmerisourceBergen Drug Corp for the supply of Reblozyl 75 mg vials. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by August 26, 2025. The contract was awarded on August 5, 2025, with performance to be executed from the vendor's location in Conshohocken, Pennsylvania. Reblozyl is a specialty pharmaceutical product used in the treatment of certain blood disorders, reflecting the Defense Logistics Agency Medical Supply Chain's critical role in providing specialized medications to military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's consistent success in competitively awarded contracts demonstrates its capability to meet stringent federal procurement requirements for pharmaceutical supply chain management.
Quick answers
Who was awarded contract SPE2DB25FJF81?
SPE2DB25FJF81 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FJF81 worth?
The government has obligated $31,565 on SPE2DB25FJF81.
Is contract SPE2DB25FJF81 an order under another contract?
Yes. SPE2DB25FJF81 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJF81 competed?
The extent of competition for SPE2DB25FJF81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award